Captrust Financial Advisors Biote Corp. Transaction History
Captrust Financial Advisors
- $34.2 Billion
- Q4 2024
A detailed history of Captrust Financial Advisors transactions in Biote Corp. stock. As of the latest transaction made, Captrust Financial Advisors holds 18,613 shares of BTMD stock, worth $81,338. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,613
Previous 20,495
9.18%
Holding current value
$81,338
Previous $114,000
1.75%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BTMD
# of Institutions
91Shares Held
18.6MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$19.9 Million12.7% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$10.6 Million5.9% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$7.01 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$6.25 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.35MShares$5.91 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $33.1M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...